Literature DB >> 10701743

Early alteration in TGF-beta mRNA expression in irradiated rat liver.

J Seong1, S H Kim, E J Chung, W J Lee, C O Suh.   

Abstract

PURPOSE: Radiation of the liver results in hepatic fibrosis as a late complication. TGF-beta has been implicated in the pathogenesis of fibrosis. The purpose of this study was to determine if there is early alteration in TGF-beta expression before hepatic fibrosis is evident. METHODS AND MATERIALS: Male Sprague-Dawley rats weighing 150-175 g were used. A partial volume of liver as large as a 2 cm x 1 cm rectangle was given a single dose of 25 Gy gamma radiation. Animals were sequentially sacrificed from day 0 to day 28. Appearance of hepatic fibrosis was tested by trichrome stain. Levels of mRNA expression of TGF-beta1 and TGF-beta3 were measured by Northern blot hybridization. Change in the level of mRNA expression was analyzed by densitometry. The expression of TGF-betas was also analyzed in tissue with immunohistochemical staining.
RESULTS: In trichrome-stained liver tissues obtained through 28 days after irradiation, there was no evidence of hepatic fibrosis. The expression of mRNAs of TGF-beta1 and TGF-beta3 showed different features; The level of TGF-beta1 mRNA showed a gradual increase to the peak level of 3.6-fold at day 28, the last analyzed time. In contrast, TGF-beta3 mRNA showed an early peak of 4.8-fold at day 7 followed by a decrease to the lowest level of 1.6-fold at the last analyzed time. The expression of TGF-betas was also analyzed in tissue with immunohistochemical staining. At day 28 after radiation, increased positive staining for TGF-beta1 was observed around the central vein. Positive staining appeared mainly in nonhepatocytic cells. For TGF-beta3, the same pattern of positive staining was observed at day 7.
CONCLUSION: The results of this study suggest that the alteration in mRNA expression of TGF-beta1 and TGF-beta3 occurs very early after radiation. The contrasting difference in the mRNA expression pattern of TGF-beta1 and TGF-beta3 suggests that interaction of the TGF-betas may be involved in fibrogenesis of irradiated liver, with TGF-beta1 as a positive regulator and TGF-beta3 as a negative regulator.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701743     DOI: 10.1016/s0360-3016(99)00401-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Hepatic Gene Expression Changes in Rats Internally Exposed to Radioactive 56MnO2 Particles at Low Doses.

Authors:  Bakhyt Ruslanova; Zhaslan Abishev; Nailya Chaizhunussova; Dariya Shabdarbayeva; Sholpan Tokesheva; Gaukhar Amantayeva; Ynkar Kairkhanova; Valeriy Stepanenko; Masaharu Hoshi; Nariaki Fujimoto
Journal:  Curr Issues Mol Biol       Date:  2021-07-22       Impact factor: 2.976

2.  MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode.

Authors:  Wentao Hu; Shuai Xu; Bin Yao; Mei Hong; Xin Wu; Hailong Pei; Lei Chang; Nan Ding; Xiaofei Gao; Caiyong Ye; Jufang Wang; Tom K Hei; Guangming Zhou
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

3.  Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.

Authors:  Masumi Imaeda; Hitoshi Ishikawa; Yukari Yoshida; Takeo Takahashi; Yu Ohkubo; Atsushi Musha; Mayumi Komachi; Yoichi Nakazato; Takashi Nakano
Journal:  J Radiat Res       Date:  2014-02-23       Impact factor: 2.724

Review 4.  Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Oncotarget       Date:  2017-09-23

5.  Helical tomotherapy for chemo-refractory multiple liver metastases.

Authors:  Taiki Takaoka; Yuta Shibamoto; Taro Murai; Masanori Kobayashi; Chikao Sugie; Yoshihiko Manabe; Takuhito Kondo; Dai Okazaki; Yuki Yamada; Akira Torii
Journal:  Cancer Med       Date:  2019-10-29       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.